Psilos Group has been a successful healthcare private equity firm since its founding in 1998 and currently has over $500 million under management. We focus our investments across the healthcare services, healthcare information technology, and medical device & instrumentation sectors. Psilos invests nationwide in businesses that are poised to create enduring market value by fundamentally improving the U.S. healthcare system. Our portfolio companies are sustainable and high value businesses that have a demonstrated ability to reduce the costs of healthcare delivery, improve clinical quality and advance the alignment of payer, patient and provider incentives.  Psilos has offices in New York, the San Francisco Bay Area and Santa Fe, New Mexico.

IntelliDOT: New Studies Show 10 Percent Reductions in Serious Five Rights-Related Errors Using Barcode Point-of-Care System for Medication Administration(pdf) 

Psilos Co-Sponsors Innovation 2009 with Health Evolution Partners (pdf) 

eBook - Quality and Cost Effectiveness as the Guideposts to Medical Device Opportunities by David Eichler and Lisa Suennen (pdf) 

Stillwater Medical Center Achieves One Million Medication Administrations with No Serious Errors Using IntelliDOT Bedside Medication Administration™ (pdf) 

New Study Shows Reduced Hospital Stay & Improved Patient Outcomes in Pediatric Patients Treated with OmniGuide's Flexible CO2 Laser Fibers (pdf) 

Psilos III Invests in SmartPill (pdf) 

Click4Care Appoints Executive Leadership Team as Medical Management Product Takes Off (pdf) 

 

 

©2006 Psilos Group All rights reserved. About Psilos | Investment Criteria | Portfolio Companies | News | Contact Us | Legal